Bayer, Janssen Say Blood Thinner Warning Claim Preempted
By Rachel Graf ( June 9, 2017, 5:44 PM EDT) -- Bayer and Janssen urged a Louisiana federal judge Thursday to toss patients' last remaining failure-to-warn claim in multidistrict litigation alleging their blood thinner Xarelto caused irreversible bleeding, saying they couldn't have changed the treatment's label to recommend a diagnostic test without approval by the U.S. Food and Drug Administration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.